SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-04-18 13:32
Tx date 2022-04-12
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,630
+600 vol
$6.05 each
6,000
Filed 2022-04-17 17:26
Tx date 2022-04-12
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$363,000
+600 vol
$605.00 each
Filed 2022-04-17 17:26
Tx date 2022-04-12
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$363,000
+600 vol
$605.00 each
6,000
Filed 2022-04-17 17:25
Tx date 2022-04-11
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,420
+400 vol
$6.05 each
5,400
Filed 2022-04-14 12:41
Tx date 2022-04-12
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,607
+900 vol
$6.23 each
12,337
Filed 2022-04-14 12:38
Tx date 2022-04-11
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,220
+200 vol
$6.10 each
1,200
Filed 2022-04-08 19:06
Tx date 2022-04-08
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,075
+500 vol
$6.15 each
1,000
Filed 2022-04-08 19:06
Tx date 2022-04-07
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,100
+500 vol
$6.20 each
500
Filed 2022-04-08 16:10
Tx date 2022-02-28
$AGN
Algernon Pharmaceuticals Inc.
Gutman, Howard
4 - Director of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 16:09
Tx date 2022-02-28
$AGN
Algernon Pharmaceuticals Inc.
Gutman, Howard
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 16:09
Tx date 2022-02-28
$AGN
Algernon Pharmaceuticals Inc.
Gutman, Howard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 16:09
Tx date 2022-04-06
$AGN
Algernon Pharmaceuticals Inc.
Gutman, Howard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,822
+2,045 vol
$6.27 each
2,045
Filed 2022-04-08 16:08
Tx date 2022-02-28
$AGN
Algernon Pharmaceuticals Inc.
Gutman, Howard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-05 18:44
Tx date 2022-04-05
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,525
+250 vol
$6.10 each
1,374
Filed 2022-04-05 18:43
Tx date 2022-04-05
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,100
+500 vol
$6.20 each
1,124
Filed 2022-04-05 18:43
Tx date 2022-04-04
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$599.00
+100 vol
$5.99 each
624
Filed 2022-04-05 18:42
Tx date 2022-04-04
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,000
+500 vol
$6.00 each
524
Filed 2022-03-28 18:51
Tx date 2022-03-28
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,641
+1,000 vol
$5.64 each
5,000
Filed 2022-03-28 18:50
Tx date 2022-03-25
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$10,594
+2,000 vol
$5.30 each
4,000
Filed 2022-01-24 13:23
Tx date 2021-03-01
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-24 13:23
Tx date 2021-03-01
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-24 13:22
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+13,500 vol
16,000
Filed 2022-01-24 13:21
Tx date 2021-11-23
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-247,500 vol
2,500
Filed 2022-01-24 13:21
Tx date 2021-03-01
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2022-01-24 13:20
Tx date 2021-03-01
$AGN
Algernon Pharmaceuticals Inc.
BRYAN, CHRISTOPHER
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-24 11:15
Tx date 2021-08-13
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-85,000 vol
0
Filed 2022-01-21 19:58
Tx date 2021-08-13
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-85,000 vol
0
Filed 2022-01-21 19:57
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+6,500 vol
11,500
Filed 2022-01-21 19:56
Tx date 2021-11-23
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-495,000 vol
5,000
Filed 2022-01-21 19:54
Tx date 2021-11-23
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,132,285 vol
11,437
Filed 2022-01-21 19:49
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
10,000
Filed 2022-01-21 19:46
Tx date 2021-09-09
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 19:38
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+6,500 vol
6,500
Filed 2022-01-21 19:37
Tx date 2021-09-16
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 19:37
Tx date 2021-09-16
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 19:37
Tx date 2021-09-16
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 19:37
Tx date 2021-09-16
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 19:31
Tx date 2021-08-13
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-425,000 vol
0
Filed 2022-01-21 19:09
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+6,500 vol
11,500
Filed 2022-01-21 19:08
Tx date 2021-11-23
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-495,000 vol
5,000
Filed 2022-01-21 19:07
Tx date 2021-11-23
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-142,285 vol
1,437
Filed 2022-01-20 13:10
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$55,349
+13,500 vol
$4.10 each
13,500
Filed 2022-01-20 13:08
Tx date 2021-12-01
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-17 12:41
Tx date 2022-01-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+32,000 vol
52,000
Filed 2022-01-17 12:39
Tx date 2022-01-12
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,769
+640 vol
$5.89 each
18,017
Filed 2022-01-17 12:37
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+800 vol
$5.00 each
15,327
Filed 2021-11-30 22:14
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,000
+4,800 vol
$5.00 each
Filed 2022-01-07 14:47
Tx date 2022-01-07
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$500.00
+100 vol
$5.00 each
21,377
Filed 2022-01-07 14:47
Tx date 2022-01-06
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$107.75
+25 vol
$4.31 each
21,277
Filed 2022-01-07 14:46
Tx date 2022-01-06
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$990.00
+225 vol
$4.40 each
21,252
Filed 2021-12-31 13:11
Tx date 2021-12-31
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,170
+500 vol
$4.34 each
21,027
Filed 2021-12-30 18:07
Tx date 2021-12-01
$AGN
Algernon Pharmaceuticals Inc.
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
24
Filed 2021-12-30 16:06
Tx date 2021-11-30
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,000
+1,400 vol
$5.00 each
2,000
Filed 2021-12-30 16:05
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,000
+600 vol
$5.00 each
600
Filed 2021-12-30 16:04
Tx date 2021-09-09
$AGN
Algernon Pharmaceuticals Inc.
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-16 14:42
Tx date 2021-12-16
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,000
+400 vol
$5.00 each
20,527
Filed 2021-12-16 10:39
Tx date 2021-12-15
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,040
+200 vol
$5.20 each
20,127
Filed 2021-12-16 10:39
Tx date 2021-12-15
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,100
+200 vol
$5.50 each
19,927
Filed 2021-12-16 10:38
Tx date 2021-12-15
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,142
+200 vol
$5.71 each
19,727
Filed 2021-11-30 22:15
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,980,000 vol
20,000
Filed 2021-11-30 22:14
Tx date 2021-11-29
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,098
+200 vol
$5.49 each
19,527
Filed 2021-11-30 22:14
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,000
+4,800 vol
$5.00 each
19,327
Filed 2021-11-30 22:13
Tx date 2021-11-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,438,250 vol
14,527
Filed 2021-11-21 14:26
Tx date 2021-11-19
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,840
-288,000 vol
$0.055 each
57,000
Filed 2021-11-21 14:26
Tx date 2021-11-17
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-210.00
-3,000 vol
$0.07 each
345,000
Filed 2021-11-05 16:52
Tx date 2021-11-01
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,040
-13,000 vol
$0.08 each
348,000
Filed 2021-10-22 16:24
Tx date 2021-10-21
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,200
-40,000 vol
$0.08 each
416,000
Filed 2021-10-16 13:21
Tx date 2021-10-12
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-340.00
-4,000 vol
$0.085 each
456,000
Filed 2021-10-08 16:36
Tx date 2021-10-07
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,286.695
-38,667 vol
$0.085 each
460,000
Filed 2021-10-08 16:36
Tx date 2021-10-04
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,150
-35,000 vol
$0.09 each
498,667
Filed 2021-10-07 16:15
Tx date 2021-10-01
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,250
-25,000 vol
$0.09 each
533,667
Filed 2021-10-07 16:15
Tx date 2021-09-28
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-475.00
-5,000 vol
$0.095 each
558,667
Filed 2021-10-07 16:14
Tx date 2021-09-24
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,085
-43,000 vol
$0.095 each
563,667
Filed 2021-08-10 23:05
Tx date 2021-02-01
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-200,000 vol
500,000
Filed 2021-08-10 23:03
Tx date 2021-02-01
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-200,000 vol
2,200,000
Filed 2021-02-19 14:23
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,000,000 vol
1,000,000
Filed 2021-02-19 14:22
Tx date 2021-01-21
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+73,118 vol
1,143,722
Filed 2021-02-19 14:22
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+70,604 vol
1,070,604
Filed 2021-02-19 14:21
Tx date 2021-01-21
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-82,500 vol
85,000
Filed 2021-02-19 14:20
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-82,500 vol
167,500
Filed 2021-02-19 14:17
Tx date 2020-07-23
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+250,000 vol
250,000
Filed 2021-02-19 14:17
Tx date 2015-10-26
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-19 14:15
Tx date 2020-10-26
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-1,000,000 vol
0
Filed 2021-02-19 14:13
Tx date 2020-04-13
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
750,000
Filed 2021-02-19 14:11
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-50,000 vol
350,000
Filed 2021-02-19 14:10
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-50,000 vol
400,000
Filed 2021-02-19 14:08
Tx date 2021-02-01
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-250,000 vol
500,000
Filed 2021-02-04 12:18
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+235,322 vol
457,415
Filed 2021-02-04 12:17
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-330,000 vol
340,000
Filed 2021-02-04 12:16
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+73,118 vol
143,722
Filed 2021-02-04 12:15
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-82,500 vol
85,000
Filed 2021-02-04 12:14
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+252,611 vol
606,667
Filed 2021-02-04 12:13
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-330,000 vol
340,000
Filed 2021-02-04 12:11
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+283,989 vol
1,452,777
Filed 2021-02-04 12:10
Tx date 2021-02-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-412,500 vol
425,000
Filed 2020-12-18 19:43
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+222,093 vol
222,093
Filed 2020-12-18 19:42
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-330,000 vol
670,000
Filed 2020-12-18 19:40
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+70,604 vol
70,604
Filed 2020-12-18 19:39
Tx date 2015-12-14
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 19:39
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-82,500 vol
167,500
Filed 2020-12-18 19:36
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+268,788 vol
1,168,788
Filed 2020-12-18 19:36
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-412,500 vol
837,500
Filed 2020-12-18 19:33
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-330,000 vol
670,000
Filed 2020-12-18 19:27
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+240,149 vol
504,056
Filed 2020-12-18 19:26
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-240,149 vol
Filed 2020-12-18 19:23
Tx date 2020-12-15
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-46,500
-150,000 vol
$0.31 each
354,056
Filed 2020-12-18 19:22
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+330,000 vol
Filed 2020-12-18 19:19
Tx date 2020-09-29
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
57 - Exercise of rights

-330,000 vol
Filed 2020-08-27 13:34
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+1,000,000 vol
1,000,000
Filed 2020-08-27 13:33
Tx date 2018-10-22
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-27 13:32
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+1,000,000 vol
1,000,000
Filed 2020-08-27 13:30
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+1,250,000 vol
1,250,000
Filed 2020-08-27 13:27
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-27 12:16
Tx date 2015-10-26
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
Filed 2020-08-27 12:16
Tx date 2015-12-14
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2020-08-27 12:14
Tx date 2020-04-13
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
700,000
Filed 2020-08-27 12:13
Tx date 2020-02-13
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
500,000
Filed 2020-08-27 12:12
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
300,000
Filed 2020-08-27 12:11
Tx date 2017-05-18
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
250,000
Filed 2020-08-27 12:10
Tx date 2015-10-26
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
Filed 2020-08-27 12:09
Tx date 2015-12-14
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-27 12:08
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+250,000 vol
250,000
Filed 2020-08-27 12:07
Tx date 2015-12-14
$AGN
Algernon Pharmaceuticals Inc.
Levine, David
4 - Director of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-27 12:05
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+1,000,000 vol
1,000,000
Filed 2020-08-27 12:05
Tx date 2020-08-21
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
56 - Grant of rights

+1,000,000 vol
Filed 2020-08-27 12:03
Tx date 2015-10-26
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights RSUs
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-16 09:36
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
$-36,000
-150,000 vol
$0.24 each
400,000
Filed 2020-07-16 09:35
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
$-37,500
-250,000 vol
$0.15 each
550,000
Filed 2020-07-16 09:31
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-381,250 vol
381,250
Filed 2020-07-16 09:28
Tx date 2019-11-25
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
$-118,750.05
-791,667 vol
$0.15 each
0
Filed 2020-06-23 20:27
Tx date 2020-04-13
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,250,000 vol
1,750,000
Filed 2020-06-23 20:26
Tx date 2020-02-13
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2020-06-23 20:24
Tx date 2018-10-22
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-06-23 20:24
Tx date 2018-10-22
$AGN
Algernon Pharmaceuticals Inc.
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-06-12 15:12
Tx date 2020-04-13
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,250,000 vol
2,000,000
Filed 2020-06-12 15:11
Tx date 2020-02-13
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
750,000
Filed 2020-06-12 15:10
Tx date 2018-10-17
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-250,000 vol
250,000
Filed 2020-06-12 15:06
Tx date 2017-10-17
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-250,000 vol
Filed 2020-06-12 15:06
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 11:51
Tx date 2017-10-17
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-250,000 vol
Filed 2019-06-05 11:49
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-15 11:32
Tx date 2020-04-13
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$290,000
+1,000,000 vol
$0.29 each
2,800,000
Filed 2020-03-02 23:09
Tx date 2020-02-25
$AGN
Algernon Pharmaceuticals Inc.
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
650,000
Filed 2020-02-26 12:45
Tx date 2020-02-13
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$100,000
+1,000,000 vol
$0.10 each
1,800,000
Filed 2020-01-09 14:57
Tx date 2020-01-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,250
+50,000 vol
$0.065 each
880,000
Filed 2020-01-09 14:57
Tx date 2020-01-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,000
+50,000 vol
$0.06 each
830,000
Filed 2020-01-09 14:54
Tx date 2020-01-03
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,300
+20,000 vol
$0.065 each
900,000
Filed 2020-01-03 06:17
Tx date 2020-01-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+100,000 vol
Filed 2020-01-03 06:17
Tx date 2020-01-02
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+100,000 vol
880,000
Filed 2019-09-30 21:17
Tx date 2019-09-27
$AGN
Algernon Pharmaceuticals Inc.
Malhi, Kulwant
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,500
+150,000 vol
$0.11 each
510,501
Filed 2019-07-23 13:55
Tx date 2019-02-08
$AGN
Algernon Pharmaceuticals Inc.
Malhi, Kulwant
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,845
+29,000 vol
$0.305 each
360,501
Filed 2019-07-23 13:54
Tx date 2019-02-08
$AGN
Breathtec BioMedical, Inc.
Malhi, Kulwant
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,845
+29,000 vol
$0.305 each
Filed 2019-02-09 14:04
Tx date 2019-02-08
$AGN
Breathtec BioMedical, Inc.
Malhi, Kulwant
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,845
+29,000 vol
$0.305 each
Filed 2019-06-05 11:54
Tx date 2019-05-24
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,200
+30,000 vol
$0.24 each
780,000
Filed 2019-06-05 11:53
Tx date 2018-10-22
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+750,000 vol
750,000
Filed 2019-06-05 11:52
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-05 11:51
Tx date 2017-10-17
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-250,000 vol
250,000
Filed 2019-06-05 11:49
Tx date 2018-03-01
$AGN
Algernon Pharmaceuticals Inc.
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2019-04-09 16:52
Tx date 2019-03-21
$AGN
Algernon Pharmaceuticals Inc.
Sadhra, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-27,692.948
-117,343 vol
$0.236 each
645,157